Jakarta, Oct. 28 -- PT Indofarma (INAF) is strengthening the downstream process of biodiversity into raw materials and nature-based pharmaceutical products by leveraging technological innovation and research collaborations with various stakeholders.

Here in Jakarta on Wednesday, Indofarma President Director Sahat Sihombing explained Indonesia's natural wealth must be explored in a more focused manner through sustained research and collaboration between the industry, universities, and research institutions.

"Indonesia is blessed with extraordinary biodiversity, including various plants that have the potential to be developed into raw materials for nature-based medicines. We need to explore the potential through scientific research, techn...